Chris CoonsFiling

Annual Report | Filed on 12 Aug 2024

This congressional financial disclosure from Chris Coons (annual report) contains 53 stock trades. It was filed on 12 August 2024. Reported tickers include BSBIX, GIBIX, RAIIX, RIPIX, IYMIX, and 27 more. Under the STOCK Act, members of Congress must disclose securities transactions within 45 days.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Politician Name
Chris Coons
Filing Type
Annual Report
Filed Date
12 Aug 2024
View Original Filing

Transactions

53 transactions
HIGFX
Purchase28 Dec 2023$1,001 - $15,000-
HIGFX
Purchase28 Dec 2023$1,001 - $15,000-
GIBIX
Purchase12 Dec 2023$1,001 - $15,000-
RAIIX
Purchase12 Dec 2023$1,001 - $15,000-
PLSRX
Purchase12 Dec 2023$1,001 - $15,000-
EIFAX
Purchase12 Dec 2023$1,001 - $15,000-
LBFIX
Sale (Partial)3 Aug 2023$1,001 - $15,000-
IXUS
Purchase5 May 2023$1,001 - $15,000-
LAHYX
Purchase5 May 2023$1,001 - $15,000-
RIPIX
Sale (Full)4 May 2023$1,001 - $15,000-
IYMIX
Purchase4 May 2023$15,001 - $50,000-
GIBIX
Purchase4 May 2023$1,001 - $15,000-
VIESX
Sale (Full)4 May 2023$1,001 - $15,000-
GQGIX
Purchase4 May 2023$1,001 - $15,000-
MCEIX
Sale (Full)4 May 2023$1,001 - $15,000-
CPEIX
Sale (Full)4 May 2023$1,001 - $15,000-
JENIX
Purchase4 May 2023$1,001 - $15,000-
PLFDX
Sale (Full)4 May 2023$1,001 - $15,000-
IXUS
Purchase6 Apr 2023$1,001 - $15,000-
VGK
Sale (Full)6 Apr 2023$1,001 - $15,000-
BSBIX
Purchase5 Apr 2023$1,001 - $15,000-
CLNRX
Sale (Full)5 Apr 2023$1,001 - $15,000-
TSYYX
Sale (Full)5 Apr 2023$15,001 - $50,000-
TSCSX
Sale (Partial)5 Apr 2023$1,001 - $15,000-
JENIX
Purchase5 Apr 2023$1,001 - $15,000-
EIFAX
Purchase5 Apr 2023$15,001 - $50,000-
Scholar's Edge Today Port...
Sale (Partial)16 Mar 2023$15,001 - $50,000-
Scholar's Edge Fixed Inco...
Sale (Partial)16 Mar 2023$1,001 - $15,000-
Scholar's Edge Aggressive...
Sale (Partial)16 Mar 2023$1,001 - $15,000-
Scholar's Edge Today Port...
Sale (Partial)16 Mar 2023$1,001 - $15,000-
VGK
Sale (Partial)7 Mar 2023$1,001 - $15,000-
MAWIX
Purchase6 Mar 2023$1,001 - $15,000-
LAHYX
Purchase6 Mar 2023$1,001 - $15,000-
TFSLX
Sale (Full)6 Mar 2023$15,001 - $50,000-
RAIIX
Purchase6 Mar 2023$1,001 - $15,000-
VGISX
Purchase6 Mar 2023$1,001 - $15,000-
Scholar's Edge Aggressive...
Sale (Partial)3 Feb 2023$1,001 - $15,000-
W.L. Gore & Associates, I...
Sale (Partial)3 Feb 2023$100,001 - $250,000-
Scholar's Edge Aggressive...
Sale (Partial)3 Feb 2023$1,001 - $15,000-
PIMSX
Sale (Full)2 Feb 2023$15,001 - $50,000-
VWUAX
Purchase2 Feb 2023$15,001 - $50,000-
CPEIX
Sale (Partial)2 Feb 2023$1,001 - $15,000-
PLSRX
Purchase2 Feb 2023$15,001 - $50,000-
PEXMX
Sale (Full)2 Feb 2023$15,001 - $50,000-
RGERX
Purchase2 Feb 2023$1,001 - $15,000-
W.L. Gore & Associates, I...
Sale (Partial)31 Jan 2023$100,001 - $250,000-
HIGFX
Purchase30 Jan 2023$1,001 - $15,000-
BSBIX
Purchase27 Jan 2023$1,001 - $15,000-
DVY
Purchase27 Jan 2023$1,001 - $15,000-
PIMSX
Sale (Full)27 Jan 2023$1,001 - $15,000-
BIOIX
Purchase27 Jan 2023$1,001 - $15,000-
GOBIX
Sale (Partial)27 Jan 2023$1,001 - $15,000-
FTHSX
Sale (Partial)27 Jan 2023$1,001 - $15,000-
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.